Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 178

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

Open access
Borisov, Sergey, Danila, Edvardas, Maryandyshev, Andrei, Dalcolmo, Margareth, Miliauskas, Skaidrius, Kuksa, Liga, Manga, Selene, Skrahina, Alena, Diktanas, Saulius, Codecasa, Luigi Ruffo, Aleksa, Alena, Bruchfeld, Judith, Koleva, Antoniya, Piubello, Alberto, Udwadia, Zarir Farokh, Akkerman, Onno W., Belilovski, Evgeny, Bernal, Enrique, Boeree, Martin J., Cadiñanos Loidi, Julen, Cai, Qingshan, Cebrian Gallardo, Jose Joaquín, Dara, Masoud, Davidavičienė, Edita, Forsman, Lina Davies, De Los Rios, Jorge, Denholm, Justin, Drakšienė, Jacinta, Duarte, Raquel, Elamin, Seifeldin Eltaeb, Escobar Salinas, Nadia, Ferrarese, Maurizio, Filippov, Alexey, Garcia, Ana, García-García, José-María, Gaudiesiute, Ieva, Gavazova, Blagovesta, Gayoso, Regina, Gomez Rosso, Roscio, Gruslys, Vygantas, Gualano, Gina, Hoefsloot, Wouter, Jonsson, Jerker, Khimova, Elena, Kunst, Heinke, Laniado-Laborín, Rafael, Li, Yang, Magis-Escurra, Cecile, Manfrin, Vinicio, Marchese, Valentina, Martínez Robles, Elena, Matteelli, Alberto, Mazza-Stalder, Jesica, Moschos, Charalampos, Muñoz-Torrico, Marcela, Mustafa Hamdan, Hamdan, Nakčerienė, Birutė, Nicod, Laurent, Nieto Marcos, Magnolia, Palmero, Domingo Juan, Palmieri, Fabrizio, Papavasileiou, Apostolos, Payen, Marie-Christine, Pontarelli, Agostina, Quirós, Sarai, Rendon, Adrian, Saderi, Laura, Šmite, Agnese, Solovic, Ivan, Souleymane, Mahamadou Bassirou, Tadolini, Marina, van den Boom, Martin, Vescovo, Marisa, Viggiani, Pietro, Yedilbayev, Askar, Zablockis, Rolandas, Zhurkin, Dmitry, Zignol, Matteo, Visca, Dina, Spanevello, Antonio, Caminero, José A., Alffenaar, Jan-Willem, Tiberi, Simon, Centis, Rosella, D'Ambrosio, Lia, Pontali, Emanuele, Sotgiu, Giovanni, Migliori, Giovanni Battista·2019·European Respiratory Journal

Abstract

The World Health Organization (WHO) recommends that countries implement pharmacovigilance and collect information on active drug safety monitoring (aDSM) and management of adverse events. The aim of this prospective study was to evaluate the frequency and severity of adverse events to anti-tuberculosis (TB) drugs in a cohort of consecutive TB patients treated with new (i.e.bedaquiline, delamanid) and repurposed (i.e.clofazimine, linezolid) drugs, based on the WHO aDSM project. Adverse events were collected prospectively after attribution to a specific drug together with demographic, bacteriological, radiological and clinical information at diagnosis and during therapy. This interim analysis included patients who completed or were still on treatment at time of data collection. Globally, 45 centres from 26 countries/regions reported 658 patients (68.7% male, 4.4% HIV co-infected) treated as follows: 87.7% with bedaquiline, 18.4% with delamanid (6.1% with both), 81.5% with linezolid and 32.4% with clofazimine. Overall, 504 adverse event episodes were reported: 447 (88.7%) were classified as minor (grade 1–2) and 57 (11.3%) as serious (grade 3–5). The majority of the 57 serious adverse events reported by 55 patients (51 out of 57, 89.5%) ultimately resolved. Among patients reporting serious adverse events, some drugs held responsible were discontinued: bedaquiline in 0.35% (two out of 577), delamanid in 0.8% (one out of 121), linezolid in 1.9% (10 out of 536) and clofazimine in 1.4% (three out of 213) of patients. Serious adverse events were reported in 6.9% (nine out of 131) of patients treated with amikacin, 0.4% (one out of 221) with ethionamide/prothionamide, 2.8% (15 out of 536) with linezolid and 1.8% (eight out of 498) with cycloserine/terizidone. The aDSM study provided valuable information, but implementation needs scaling-up to support patient-centred care.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1183/13993003.01522-2019

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 178

Metadata

Authors
Borisov, S., Danila, E., Maryandyshev, A., Dalcolmo, M., Miliauskas, S., Kuksa, L., Manga, S., Skrahina, A., Diktanas, S., Codecasa, L. R., Aleksa, A., Bruchfeld, J., Koleva, A., Piubello, A., Udwadia, Z. F., Akkerman, O. W., Belilovski, E., Bernal, E., Boeree, M. J., Cadiñanos Loidi, J., Cai, Q., Cebrian Gallardo, J. J., Dara, M., Davidavičienė, E., Forsman, L. D., De Los Rios, J., Denholm, J., Drakšienė, J., Duarte, R., Elamin, S. E., Escobar Salinas, N., Ferrarese, M., Filippov, A., Garcia, A., García-García, J.-M., Gaudiesiute, I., Gavazova, B., Gayoso, R., Gomez Rosso, R., Gruslys, V., Gualano, G., Hoefsloot, W., Jonsson, J., Khimova, E., Kunst, H., Laniado-Laborín, R., Li, Y., Magis-Escurra, C., Manfrin, V., Marchese, V., Martínez Robles, E., Matteelli, A., Mazza-Stalder, J., Moschos, C., Muñoz-Torrico, M., Mustafa Hamdan, H., Nakčerienė, B., Nicod, L., Nieto Marcos, M., Palmero, D. J., Palmieri, F., Papavasileiou, A., Payen, M.-C., Pontarelli, A., Quirós, S., Rendon, A., Saderi, L., Šmite, A., Solovic, I., Souleymane, M. B., Tadolini, M., van den Boom, M., Vescovo, M., Viggiani, P., Yedilbayev, A., Zablockis, R., Zhurkin, D., Zignol, M., Visca, D., Spanevello, A., Caminero, J. A., Alffenaar, J.-W., Tiberi, S., Centis, R., D'Ambrosio, L., Pontali, E., Sotgiu, G., & Migliori, G. B.
Venue
European Respiratory Journal
Published
2019-10-10
Volume
54
Issue
6
Pages
1901522
ISSN
  • 0903-1936 (ISSN-L)
  • 1399-3003
OpenAlex
W2979539159
Cited by
178
References
1
FWCI
18.70
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report. https://app.cochat.ai/papers/10.1183/13993003.01522-2019
The paper
Borisov, S., Danila, E., Maryandyshev, A., Dalcolmo, M., Miliauskas, S., Kuksa, L., Manga, S., Skrahina, A., Diktanas, S., Codecasa, L. R., Aleksa, A., Bruchfeld, J., Koleva, A., Piubello, A., Udwadia, Z. F., Akkerman, O. W., Belilovski, E., Bernal, E., Boeree, M. J., . . . Migliori, G. B. (2019). Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report. European Respiratory Journal. https://doi.org/10.1183/13993003.01522-2019

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.